Lupin receives approval from U.S. FDA for Varenicline Tablets
Varenicline Tablets, 0.5 mg and 1 mg are indicated for use as an aid to smoking cessation treatment.
Varenicline Tablets, 0.5 mg and 1 mg are indicated for use as an aid to smoking cessation treatment.
This product will be manufactured by Indoco Remedies at their manufacturing facility located at Goa
Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of USD 136.5 mn in the United States
Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US
Canagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor
Dapagliflozin Tablets (RLD Farxiga) had estimated annual sales of USD 7282 million in the US
Pitavastatin Tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol
This product will be manufactured at Lupin’s Pithampur facility in India
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Subscribe To Our Newsletter & Stay Updated